Does Obesity Increase Respiratory Tract Infections in Patients with Asthma?
暂无分享,去创建一个
L. Que | S. Peters | W. Teague | Lewis J Smith | R. Wise | J. Lang | A. Dixon | J. Holbrook | Monica Tang | L. Rogers | R. Henderson | A. Mathews | L. Smith | Robert Henderson
[1] J. Celedón,et al. Adiposity and Asthma in a Nationwide Study of Children and Adults in the United States , 2017, Annals of the American Thoracic Society.
[2] M. Castro,et al. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial. , 2017, The journal of allergy and clinical immunology. In practice.
[3] M. Hudgens,et al. Increased risk of influenza among vaccinated adults who are obese , 2017, International Journal of Obesity.
[4] Catherine M. Hayes,et al. Hyperleptinemia is associated with impaired pulmonary host defense. , 2016, JCI insight.
[5] A. Linneberg,et al. Body Mass Index and Risk of Infections Among Women in the Danish National Birth Cohort. , 2016, American journal of epidemiology.
[6] W. Teague,et al. Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype. , 2015, Annals of the American Thoracic Society.
[7] J. Lam,et al. Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis , 2015, PloS one.
[8] Lewis J Smith,et al. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial. , 2015, JAMA.
[9] Obesity and asthma: the chicken or the egg? , 2015, The Journal of allergy and clinical immunology.
[10] J. Lang,et al. Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures. , 2015, The Journal of allergy and clinical immunology.
[11] M. Castro,et al. Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma. , 2015, The Journal of allergy and clinical immunology.
[12] F. Rasmussen,et al. Mechanisms of obesity in asthma , 2014, Current opinion in allergy and clinical immunology.
[13] J. Rathmell,et al. Leptin Metabolically Licenses T Cells for Activation To Link Nutrition and Immunity , 2014, The Journal of Immunology.
[14] W. Teague,et al. Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children. , 2013, The Journal of pediatrics.
[15] K. To,et al. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. , 2013, The Journal of infectious diseases.
[16] S. Johnston,et al. Obesity and susceptibility to severe outcomes following respiratory viral infection , 2013, Thorax.
[17] L. Boulet,et al. Asthma and obesity , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[18] G. Caire-Juvera,et al. Decreased interferon-α and interferon-β production in obesity and expression of suppressor of cytokine signaling. , 2013, Nutrition.
[19] R. Pratley,et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. , 2012, American journal of respiratory and critical care medicine.
[20] J. Lang. Obesity, Nutrition, and Asthma in Children. , 2012, Pediatric allergy, immunology, and pulmonology.
[21] M. Sockrider,et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. , 2012, JAMA.
[22] Seemalata Jain,et al. Obesity and influenza. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] K. Obstein,et al. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. , 2011, Archives of internal medicine.
[24] Budget.. Fiscal Year 2012 , 2011 .
[25] G. Triadafilopoulos,et al. Adverse Effects of Long-Term Proton Pump Inhibitor Therapy , 2011, Digestive Diseases and Sciences.
[26] William W Busse,et al. Role of viral respiratory infections in asthma and asthma exacerbations , 2010, The Lancet.
[27] T. Kiljander,et al. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. , 2010, American journal of respiratory and critical care medicine.
[28] C. Rand,et al. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. , 2009, The Journal of allergy and clinical immunology.
[29] P. Succop,et al. Comparison of anthropometric measures of obesity in childhood allergic asthma: central obesity is most relevant. , 2009, The Journal of allergy and clinical immunology.
[30] N. Anthonisen,et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. , 2009, The New England journal of medicine.
[31] N. Anthonisen,et al. Randomized comparison of strategies for reducing treatment in mild persistent asthma. , 2007, The New England journal of medicine.
[32] Gulshan Sharma,et al. Effect of aging on respiratory system physiology and immunology , 2006, Clinical interventions in aging.
[33] M. Falagas,et al. Obesity and infection. , 2006, The Lancet. Infectious diseases.
[34] F. Manguso,et al. Therapy With Gastric Acidity Inhibitors Increases the Risk of Acute Gastroenteritis and Community-Acquired Pneumonia in Children , 2006, Pediatrics.
[35] Stephen T Holgate,et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study , 2002, The Lancet.
[36] E. Rimm,et al. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. , 2000, Archives of internal medicine.
[37] W. Jędrychowski,et al. Predisposition to acute respiratory infections among overweight preadolescent children: an epidemiologic study in Poland. , 1998, Public health.
[38] R. Brant,et al. Prevalence of gastroesophageal reflux symptoms in asthma. , 1996, Chest.
[39] S. Johnston,et al. Viruses as precipitants of asthma symptoms II. Physiology and mechanisms , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[40] J. Wandall,et al. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. , 1992, Gut.